| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.674 | 0.036 | 0.81 | Antiinflammatory | 0.81 0.014 CID_154699950 | CID_154699950 | |
| 0.582 | 0.005 | 0.791 | Non-steroidal antiinflammatory agent | 0.791 0.003 CID_154699950 | CID_154699950 | |
| 0.552 | 0.036 | 0.552 | Analgesic | 0.329 0.121 CID_154699950 | ||
| 0.42 | 0.004 | 0.42 | Interleukin 8 antagonist | 0.106 0.083 CID_154699950 | ||
| 0.47 | 0.06 | 0.657 | Cyclophilin D inhibitor | 0.657 0.019 CID_154699950 | CID_154699950 | |
| 0.423 | 0.032 | 0.423 | Lipoxygenase inhibitor | |||
| 0.384 | 0.008 | 0.384 | Cyclooxygenase inhibitor | 0.311 0.016 CID_154699950 | ||
| 0.382 | 0.008 | 0.382 | Cyclooxygenase 1 inhibitor | 0.285 0.016 CID_154699950 | ||
| 0.302 | 0.013 | 0.302 | Cyclooxygenase 2 inhibitor | 0.235 0.023 CID_154699950 | ||
| 0.292 | 0.007 | 0.324 | ATPase inhibitor | 0.324 0.005 CID_154699950 | CID_154699950 | |
| 0.267 | 0.008 | 0.529 | Cyclooxygenase 3 inhibitor | 0.529 0.003 CID_154699950 | CID_154699950 | |
| 0.315 | 0.064 | 0.433 | Interleukin 2 agonist | 0.433 0.019 CID_154699950 | CID_154699950 | |
| 0.24 | 0.009 | 0.24 | Potassium channel (Ca-activated) activator | |||
| 0.225 | 0.014 | 0.225 | Arachidonic acid antagonist | 0.132 0.11 CID_154699950 | ||
| 0.264 | 0.057 | 0.264 | Interleukin antagonist | |||
| 0.211 | 0.005 | 0.211 | Prostaglandin-E synthase inhibitor | |||
| 0.211 | 0.006 | 0.211 | Prostaglandin antagonist | |||
| 0.294 | 0.096 | 0.294 | Thyroid hormone antagonist | |||
| 0.281 | 0.097 | 0.281 | Sodium/bile acid cotransporter inhibitor | |||
| 0.21 | 0.031 | 0.229 | Insulin secretagoues | 0.229 0.024 CID_154699950 | CID_154699950 | |
| 0.234 | 0.057 | 0.234 | Anesthetic general | 0.177 0.089 CID_154699950 | ||
| 0.212 | 0.037 | 0.326 | Interferon gamma antagonist | 0.326 0.017 CID_154699950 | CID_154699950 | |
| 0.29 | 0.117 | 0.29 | Toll-Like receptor 7 agonist | |||
| 0.282 | 0.122 | 0.282 | Toll-Like receptor agonist | |||
| 0.265 | 0.109 | 0.265 | Thyroid hormone beta antagonist | |||
| 0.186 | 0.033 | 0.186 | MAP kinase kinase inhibitor | |||
| 0.157 | 0.014 | 0.157 | MAP kinase kinase 1 inhibitor | |||
| 0.222 | 0.081 | 0.231 | Hypolipemic | 0.231 0.077 CID_154699950 | CID_154699950 | |
| 0.17 | 0.034 | 0.17 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.212 | 0.077 | 0.212 | ErbB-1 antagonist | |||
| 0.206 | 0.079 | 0.206 | Nitric-oxide synthase stimulant | 0.19 0.108 CID_154699950 | ||
| 0.137 | 0.01 | 0.137 | Bile acid receptor antagonist | |||
| 0.135 | 0.012 | 0.135 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.184 | 0.063 | 0.184 | Succinate dehydrogenase inhibitor | |||
| 0.16 | 0.042 | 0.16 | Farnesoid X receptor antagonist | |||
| 0.139 | 0.028 | 0.139 | DOPA decarboxylase inhibitor | |||
| 0.144 | 0.039 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.22 | 0.119 | 0.22 | Gastrin inhibitor | |||
| 0.129 | 0.032 | 0.129 | DNA directed RNA polymerase inhibitor | 0.092 0.067 CID_154699950 | ||
| 0.234 | 0.137 | 0.39 | Cholesterol antagonist | 0.39 0.052 CID_154699950 | CID_154699950 | |
| 0.198 | 0.101 | 0.313 | Antiamyloidogenic | 0.313 0.048 CID_154699950 | CID_154699950 | |
| 0.136 | 0.043 | 0.136 | 5-Lipoxygenase inhibitor | |||
| 0.141 | 0.053 | 0.141 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.278 | 0.191 | 0.278 | 5 Hydroxytryptamine release inhibitor | 0.244 0.236 CID_154699950 | ||
| 0.136 | 0.05 | 0.154 | CC chemokine 6 receptor antagonist | 0.154 0.018 CID_154699950 | CID_154699950 | |
| 0.095 | 0.013 | 0.095 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.133 | 0.053 | 0.133 | Interleukin 1b antagonist | |||
| 0.092 | 0.014 | 0.141 | Phosphorylase inhibitor | 0.141 0.008 CID_154699950 | CID_154699950 | |
| 0.082 | 0.005 | 0.082 | Prostaglandin D2 antagonist | |||
| 0.113 | 0.036 | 0.113 | ABCA1 expression enhancer | |||
| 0.179 | 0.104 | 0.179 | EphB2 antagonist | |||
| 0.082 | 0.008 | 0.082 | CXC chemokine 1 receptor antagonist | |||
| 0.22 | 0.148 | 0.356 | Angiogenesis inhibitor | 0.356 0.069 CID_154699950 | CID_154699950 | |
| 0.096 | 0.026 | 0.096 | Potassium channel large-conductance Ca-activated activator | |||
| 0.087 | 0.017 | 0.087 | Prostaglandin F2 alpha antagonist | |||
| 0.121 | 0.053 | 0.121 | Ferrochelatase inhibitor | |||
| 0.076 | 0.009 | 0.076 | Dihydroorotase inhibitor | |||
| 0.133 | 0.068 | 0.146 | Interleukin 4 antagonist | 0.146 0.053 CID_154699950 | CID_154699950 | |
| 0.12 | 0.056 | 0.12 | Estrogen antagonist | |||
| 0.106 | 0.043 | 0.106 | NMDA receptor antagonist | |||
| 0.081 | 0.019 | 0.081 | Thromboxane antagonist | |||
| 0.154 | 0.096 | 0.154 | Catenin beta inhibitor | |||
| 0.075 | 0.018 | 0.075 | Thromboxane A2 antagonist | |||
| 0.102 | 0.045 | 0.102 | Potassium channel activator | |||
| 0.09 | 0.037 | 0.09 | Keratolytic | |||
| 0.087 | 0.036 | 0.087 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.075 | 0.025 | 0.075 | Aldose reductase inhibitor | 0.048 0.041 CID_154699950 | ||
| 0.138 | 0.088 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.09 | 0.044 | 0.09 | D-Ala-D-Ala ligase inhibitor | |||
| 0.1 | 0.054 | 0.1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.096 0.058 CID_154699950 | ||
| 0.065 | 0.022 | 0.065 | Pregnane X receptor antagonist | |||
| 0.179 | 0.136 | 0.406 | Hypoglycemic | 0.406 0.027 CID_154699950 | CID_154699950 | |
| 0.047 | 0.005 | 0.047 | Thyroid hormone agonist | |||
| 0.056 | 0.015 | 0.056 | Liver X receptor alpha agonist | |||
| 0.134 | 0.097 | 0.134 | MAP kinase 3 inhibitor | |||
| 0.062 | 0.026 | 0.062 | Leukotriene C antagonist | |||
| 0.1 | 0.064 | 0.1 | Estrogen receptor beta antagonist | |||
| 0.061 | 0.026 | 0.09 | Adenine nucleotide translocase inhibitor | 0.09 0.006 CID_154699950 | CID_154699950 | |
| 0.19 | 0.155 | 0.19 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.061 | 0.027 | 0.061 | DNA helicase inhibitor | |||
| 0.045 | 0.012 | 0.045 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.055 | 0.022 | 0.055 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.059 | 0.027 | 0.059 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.043 | 0.011 | 0.043 | ATP citrate lysase inhibitor | |||
| 0.13 | 0.099 | 0.13 | Src kinase inhibitor | |||
| 0.066 | 0.036 | 0.066 | Purinergic P2X1 antagonist | |||
| 0.103 | 0.073 | 0.103 | Cystathionine beta-synthase inhibitor | |||
| 0.057 | 0.028 | 0.057 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.119 | 0.09 | 0.119 | Interleukin 1 antagonist | |||
| 0.037 | 0.009 | 0.037 | CXC chemokine 2 receptor antagonist | |||
| 0.217 | 0.189 | 0.217 | Calcium channel activator | |||
| 0.109 | 0.081 | 0.109 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.051 | 0.024 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.092 | 0.068 | 0.092 | Interleukin 12 antagonist | 0.089 0.075 CID_154699950 | ||
| 0.188 | 0.165 | 0.188 | 12-Lipoxygenase inhibitor | |||
| 0.055 | 0.032 | 0.094 | Heparanase inhibitor | 0.094 0.004 CID_154699950 | CID_154699950 | |
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | |||
| 0.061 | 0.04 | 0.061 | Prostaglandin EP2 antagonist | |||
| 0.035 | 0.014 | 0.035 | Elastase 3B inhibitor | |||
| 0.035 | 0.014 | 0.035 | Elastase 2B inhibitor | |||
| 0.035 | 0.014 | 0.035 | Elastase 3A inhibitor | |||
| 0.071 | 0.051 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.145 | 0.126 | 0.145 | MAP kinase kinase 2 inhibitor | |||
| 0.098 | 0.078 | 0.098 | Protein kinase (CK2) alpha inhibitor | |||
| 0.031 | 0.012 | 0.031 | NMDA receptor glycine site antagonist | |||
| 0.068 | 0.05 | 0.068 | Elastase 1 inhibitor | |||
| 0.023 | 0.005 | 0.023 | Thyroid hormone alpha agonist | |||
| 0.072 | 0.054 | 0.072 | CDC25A inhibitor | |||
| 0.046 | 0.028 | 0.046 | NMDA receptor subunit 3B antagonist | |||
| 0.092 | 0.077 | 0.092 | Urease inhibitor | |||
| 0.033 | 0.018 | 0.033 | Prostaglandin agonist | |||
| 0.089 | 0.075 | 0.089 | Electrolyte absorption antagonist | |||
| 0.085 | 0.071 | 0.085 | Alcohol dehydrogenase inhibitor | |||
| 0.027 | 0.013 | 0.027 | Prostaglandin E2 agonist | |||
| 0.067 | 0.054 | 0.067 | NMDA 2 receptor antagonist | |||
| 0.031 | 0.019 | 0.031 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.073 | 0.061 | 0.073 | Macrophage migration inhibitory factor inhibitor | |||
| 0.069 | 0.057 | 0.069 | Glutamate decarboxylase inhibitor | |||
| 0.041 | 0.03 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.084 | 0.073 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.073 | 0.062 | 0.073 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.038 | 0.027 | 0.038 | NMDA receptor subunit 3A antagonist | |||
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha antagonist | |||
| 0.087 | 0.077 | 0.087 | Creatine kinase inhibitor | |||
| 0.025 | 0.015 | 0.025 | Prostaglandin EP2 agonist | |||
| 0.038 | 0.029 | 0.038 | Leukotriene C4 antagonist | |||
| 0.013 | 0.004 | 0.013 | Thyroid hormone beta agonist | |||
| 0.091 | 0.082 | 0.091 | Carbonic anhydrase XV inhibitor | |||
| 0.06 | 0.051 | 0.064 | CDC25B inhibitor | 0.064 0.045 CID_154699950 | CID_154699950 | |
| 0.102 | 0.094 | 0.245 | Amylase inhibitor | 0.245 0.029 CID_154699950 | CID_154699950 | |
| 0.079 | 0.071 | 0.079 | Estrogen-related receptor beta agonist | |||
| 0.058 | 0.051 | 0.058 | NMDA receptor agonist | |||
| 0.036 | 0.032 | 0.036 | Glutamate (mGluR8) agonist | |||
| 0.08 | 0.077 | 0.103 | Triose-phosphate isomerase inhibitor | 0.103 0.045 CID_154699950 | CID_154699950 | |
| 0.09 | 0.086 | 0.169 | AMP-activated protein kinase stimulant | 0.169 0.018 CID_154699950 | CID_154699950 | |
| 0.027 | 0.024 | 0.027 | Liver X receptor alpha antagonist | |||
| 0.185 | 0.184 | 0.185 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.062 | 0.06 | 0.062 | Histidine decarboxylase inhibitor | |||
| 0.118 | 0.121 | 0.202 | Hexokinase inhibitor | 0.202 0.034 CID_154699950 | CID_154699950 | |
| 0.073 | 0.089 | 0.126 | Transcription factor NF kappa B stimulant | 0.126 0.023 CID_154699950 | CID_154699950 | |
| 0.176 | 0.195 | 0.561 | Transcription factor NF kappa B inhibitor | 0.561 0.036 CID_154699950 | CID_154699950 | |
| 0.235 | 0.272 | 0.315 | Caspase 9 stimulant | 0.315 0.178 CID_154699950 | CID_154699950 | |
| 0.078 | 0.121 | 0.168 | Toll-Like receptor 4 antagonist | 0.168 0.013 CID_154699950 | CID_154699950 | |
| 0.033 | 0.096 | 0.077 | Factor IXa inhibitor | 0.077 0.017 CID_154699950 | CID_154699950 | |
| 0.081 | 0.146 | 0.16 | Cell adhesion inhibitor | 0.16 0.041 CID_154699950 | CID_154699950 | |
| 0.071 | 0.138 | 0.219 | Beta glucuronidase inhibitor | 0.219 0.011 CID_154699950 | CID_154699950 | |
| 0.165 | 0.236 | 0.439 | Immunosuppressant | 0.439 0.05 CID_154699950 | CID_154699950 | |
| 0.104 | 0.176 | 0.128 | Melanin inhibitor | 0.128 0.118 CID_154699950 | CID_154699950 | |
| 0.097 | 0.179 | 0.194 | Hemostatic | 0.194 0.035 CID_154699950 | CID_154699950 | |
| 0.113 | 0.201 | 0.204 | Interleukin agonist | 0.204 0.117 CID_154699950 | CID_154699950 | |
| 0.028 | 0.116 | 0.274 | Selectin antagonist | 0.274 0.007 CID_154699950 | CID_154699950 | |
| 0.153 | 0.246 | 0.347 | Antithrombotic | 0.347 0.066 CID_154699950 | CID_154699950 | |
| 0.052 | 0.145 | 0.091 | Cell adhesion molecule inhibitor | 0.091 0.042 CID_154699950 | CID_154699950 | |
| 0.009 | 0.108 | 0.039 | Sodium/glucose cotransporter 2 inhibitor | 0.039 0.009 CID_154699950 | CID_154699950 | |
| 0.109 | 0.21 | 0.387 | Free radical scavenger | 0.387 0.031 CID_154699950 | CID_154699950 | |
| 0.012 | 0.115 | 0.036 | Sodium/glucose cotransporter inhibitor | 0.036 0.008 CID_154699950 | CID_154699950 | |
| 0.064 | 0.171 | 0.141 | Multidrug resistance-associated protein 1 inhibitor | 0.141 0.03 CID_154699950 | CID_154699950 | |
| 0.114 | 0.223 | 0.434 | Antioxidant | 0.434 0.029 CID_154699950 | CID_154699950 | |
| 0.089 | 0.198 | 0.191 | NOS3 expression enhancer | 0.191 0.045 CID_154699950 | CID_154699950 | |
| 0.056 | 0.165 | 0.098 | NADH dehydrogenase inhibitor | 0.098 0.046 CID_154699950 | CID_154699950 | |
| 0.041 | 0.158 | 0.139 | Monophenol monooxygenase inhibitor | 0.139 0.051 CID_154699950 | CID_154699950 | |
| 0.089 | 0.208 | 0.272 | Nitric oxide antagonist | 0.272 0.046 CID_154699950 | CID_154699950 | |
| 0.065 | 0.186 | 0.221 | Lipid peroxidase inhibitor | 0.221 0.034 CID_154699950 | CID_154699950 | |
| 0.098 | 0.223 | 0.413 | Immunostimulant | 0.413 0.046 CID_154699950 | CID_154699950 | |
| 0.05 | 0.181 | 0.142 | UDP-glucose 4-epimerase inhibitor | 0.142 0.032 CID_154699950 | CID_154699950 | |
| 0.084 | 0.23 | 0.293 | Hepatoprotectant | 0.293 0.032 CID_154699950 | CID_154699950 | |
| 0.119 | 0.279 | 0.203 | DNA synthesis inhibitor | 0.203 0.118 CID_154699950 | CID_154699950 | |
| 0.079 | 0.24 | 0.286 | Platelet adhesion inhibitor | 0.286 0.038 CID_154699950 | CID_154699950 | |
| 0.082 | 0.263 | 0.163 | Platelet antagonist | 0.163 0.132 CID_154699950 | CID_154699950 | |
| 0.119 | 0.313 | 0.299 | Peptidyltransferase inhibitor | 0.299 0.025 CID_154699950 | CID_154699950 | |
| 0.048 | 0.245 | 0.181 | Thrombolytic | 0.181 0.062 CID_154699950 | CID_154699950 | |
| 0.055 | 0.26 | 0.427 | Angiogenesis stimulant | 0.427 0.018 CID_154699950 | CID_154699950 | |
| 0.044 | 0.259 | 0.095 | DNA polymerase I inhibitor | 0.095 0.091 CID_154699950 | CID_154699950 | |
| 0.124 | 0.344 | 0.33 | Apoptosis antagonist | 0.33 0.066 CID_154699950 | CID_154699950 | |
| 0.016 | 0.237 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.076 0.021 CID_154699950 | CID_154699950 | |
| 0.101 | 0.327 | 0.416 | Alpha-glucosidase inhibitor | 0.416 0.108 CID_154699950 | CID_154699950 | |
| 0.014 | 0.262 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.019 CID_154699950 | CID_154699950 | |
| 0.01 | 0.274 | 0.096 | Antineoplastic antibiotic | 0.096 0.048 CID_154699950 | CID_154699950 | |
| 0.007 | 0.296 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.017 CID_154699950 | CID_154699950 | |
| 0.062 | 0.359 | 0.33 | Tumour necrosis factor alpha release inhibitor | 0.33 0.043 CID_154699950 | CID_154699950 | |
| 0.027 | 0.328 | 0.099 | Alkylator | 0.099 0.089 CID_154699950 | CID_154699950 | |
| 0.089 | 0.392 | 0.314 | Immunomodulator | 0.314 0.075 CID_154699950 | CID_154699950 | |
| 0.04 | 0.349 | 0.125 | Anticoagulant | 0.125 0.106 CID_154699950 | CID_154699950 | |
| 0.083 | 0.439 | 0.555 | Antibacterial | 0.555 0.027 CID_154699950 | CID_154699950 | |
| 0.012 | 0.454 | 0.05 | Antibiotic Aminoglycoside-like | 0.05 0.014 CID_154699950 | CID_154699950 | |
| 0.078 | 0.538 | 0.46 | Apoptosis agonist | 0.46 0.087 CID_154699950 | CID_154699950 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |